CHR-3996 新

参考资料仅供科学研究，不可用于个人用途。

货号：BCP44113CAS号：1235859-13-8纯度：98%

在线咨询

购买咨询

全国免运费！免费咨询：400-099-8200 或手机联系：13472751340

* 必填项

请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。

* Required Fields.

Please complete the form below and we will contact you shortly.

* Required Fields.

Please complete the form below and we will contact you shortly.

CAS号	1235859-13-8	货号	BCP44113
中文名	CHR-3996
英文名	CHR-3996
中文别名
英文别名	CHR3996;CHR 3996;
SMILES	C1C(CC2C1C2NCC3=NC4=C(C=C3)C=C(C=C4)F)C5=NC=C(C=N5)C(=O)NO
化学名称
分子式	C21H20FN5O2	分子量	393.41
纯度	98%	配送	惯例下常温包邮
产品描述	CHR-3996 is an orally bioavailable, second-generation hydroxamic acid-based inhibitor of histone deacetylase (HDAC) with potential antineoplastic activity. HDAC inhibitor CHR-3996 inhibits HDAC, resulting in an accumulation of highly acetylated histones, the induction of chromatin remodeling, and the selective transcription of tumor suppressor genes; these events may result in the inhibition of tumor cell division and the induction of tumor cell apoptosis. This agent may upregulate HSP70 and downregulate anti-apoptotic Bcl-2 proteins more substantially than some first-generation HDAC inhibitors. HDACs, upregulated in many tumor cell types, are a family of metalloenzymes responsible for the deacetylation of chromatin histone proteins.